Prothena (PRTA) Tumbles 18% in a Year: What Lies Ahead?
Prothena's (PRTA) stock tumbles more than 18% due to a pipeline setback. The company depends heavily on the success of its two candidates.
Roche MS Drug Ocrevus Gets Marketing Authorization in Europe
Roche's (RHHBY) multiple sclerosis drug Ocrevus gets approval in Europe thereby boosting its neuroscience portfolio. The drug is already approved in the United States.
Brawny pickups, futuristic SUVs star at Detroit auto show
It's the year of the pickup truck at the 2018 North American International Auto Show in Detroit as General Motors, Fiat Chrysler and Ford unveil new trucks in a fast-growing and highly competitive U.S. ...
4 Ways to Avoid Getting Hurt by Capital Gains Taxes
Whenever you make money from an investment, the IRS wants a piece of your profits. Here's how to keep more of those proceeds for yourself.
5 Social Security Changes to Expect by 2020
Everyone from working Americans who are decades from retirement to current retirees could be affected.
3 Dividend Stocks That Thrive in Both Bull and Bear Markets
Three companies that have proved they can do well no matter the market conditions.
Why we need Women with Drive
